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Experiments have confirmed that cerebrospinal
fluid drainage (CSFD)1-3 or hypothermia4-6 used
during replacement of the thoracoabdominal aorta
significantly reduces the risk of paralysis. We have
found that these adjuncts used together with endor-
phin receptor blockade can reduce our patients’
paraplegia risk to between one seventh and one
tenth of the risk of graft inclusion with intercostal
reimplantation, with or without assisted circula-
tion.7,8 However, the amount of aorta replaced and
the clinical presentation (i.e., acute, dissection, or
both) continue to be risk factors for paralysis. This
report details our efforts to define additional factors
that affect the risk for paraplegia in this group of
patients.
METHODS
We studied preoperative and operative factors for
paraplegia risk and survival for 217 consecutive
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Purpose: We studied factors that influence paralysis risk, renal function, and mortality in
thoracoabdominal aortic replacement.
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or assisted circulation. One hundred fifty patients (group A) received cerebrospinal fluid
drainage (CSFD) and low-dose naloxone (1 m g/kg/hour) as adjuncts to reduce the risk
of paralysis. Sixty-seven patients (group B) did not receive CSFD and naloxone.
Results: Seventeen deficits occurred in 205 surviving patients: 5 of the 147 in group A
(expected deficits = 31) and 12 of the 58 in group B (expected deficits = 13) (p < 0.001).
In a multivariate logistic regression model, acute presentation, Crawford type 2
aneurysm, group B membership, and a decrease in cardiac index with aortic occlusion
remained significant risk factors for deficit (p < 0.0001). By odds ratio analysis, group
A patients had 1/40th the risk of paralysis of group B. The only significant predictor of
postoperative renal function was the preoperative creatinine level (p < 0.0001); renal
revascularization significantly improved renal function. The mortality rate was 1.6% (2)
for patients undergoing elective treatment and 21% (19) for patients who had acute pre-
sentations. Acute presentation, age, and the preoperative creatinine level were found to
be significant factors for operative mortality in a logistic regression model (p < 0.001)
and defined a group at high risk for death.
Conclusions: CSFD and low-dose naloxone significantly reduce the paralysis risk associ-
ated with thoracoabdominal aortic replacement. A decrease in the cardiac index with
aortic occlusion is a previously unreported variable that defines a subset of patients at
higher risk for paralysis. (J Vasc Surg 1998;27:821-30.)
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patients treated for thoracoabdominal and thoracic
aneurysms from 1984 through 1996 (Table I).
Crawford’s classification (Crawford type designated
as C1, C2, C3, C4) was used to label the extent of
aortic replacement, and patients were grouped by
clinical presentation as acute (i.e., rupture, con-
tained rupture, or acute dissection) or dissection
(i.e., chronic or acute) cases.
Patients with Stanford type B acute dissection
treated with short-segment thoracic replacement
were classified as patients with acute thoracic
aneurysms. Hemodynamic measurements were
recorded before, during, and after aortic occlusion,
as were cerebrospinal fluid (CSF) gases. Blood gases
were recorded before and after aortic occlusion, and
serum and CSF glucose concentrations were mea-
sured during aortic occlusion.
The operative and anesthetic technique used has
been described elsewhere.9 In general, it consists of
simple aortic cross-clamping without assisted circula-
tion, moderate hypothermia, renal cooling, cere-
brospinal fluid drainage (CSFD), low-dose naloxone,
and immediate intercostal ligation with no intercostal
reimplantation.9
Patients who had CSF drainage and naloxone
were classified as group A, and those who did not
were classified as group B. Univariate analysis was per-
formed for all variables to assess paraplegia and mor-
tality risk. Significant (p < 0.05) variables were ana-
lyzed with multivariate logistic models to identify the
strongest associations for paraplegia and death and to
gain insight into how these variables interact. Implicit
in this type of analysis is the understanding that fac-
tors other than those identified may be important but
not significant in the analysis because of the small
number of outcome events (i.e., type 2 error). All sta-
tistical analyses were performed with JMP and
StatView software for the Macintosh; all results were
independently verified with SAS software.
We calculated the expected paraplegia rates for
patients in groups A and B with our previously
reported and confirmed accurate paraplegia predic-
tive model:
Expected deficits = [(C1 · 0.1) + (C2 · 0.2) +
(C3 · 0.05) + (C4 · 0.02) + (TA · 0.01)] + [(Acute
+ Dissection) x 0.3].7,10
To avoid overestimating expected paralysis rates
for our patients, we designated acute dissections as
thoracic aneurysms when a short thoracic graft was
used in repair. Acute thoracic aneurysms with or
without dissection were not counted as acute or dis-
section categories in the model because of their
lower paralysis risk compared with more extensive
thoracoabdominal replacements.
RESULTS
Two hundred seventeen patients (131 male)
between 13 and 88 years of age (mean, 66.9 years)
were surgically treated for 176 thoracoabdominal
aneurysms and 41 descending thoracic aortic
aneurysms. Of these patients, 90 (41%) had acute
presentations and 29 (13%) had dissections. One
hundred sixty-four (76%) had atherosclerosis (Table
II), and 66 (30%) had Crawford type 2 aneurysms
(Table III). Two hundred five (96.5%) survived long
enough to determine their neurologic status.
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Table I. Preoperative and operative factors measured for paraplegia (deficit) risk. 
Preoperative factors Operative factors
Procedure year Drug time and dose
Aorta replaced because of C1, C2, C3, or C4 aneurysms Naloxone
or thoracic aneurysm
Clinical presentation (e.g., elective, acute, dissection) Volume replacement
Age Temperature
Gender Pulmonary artery pressure
Aneurysm size Mean arterial pressure
Pathology Cardiac index
Renal function CVP
Previous aortic surgery PO2
Myocardial infarction pH
Coronary artery bypass graft CSF PO2
Abnormal thallium stress test result CSF drainage
Vasoactive drugs (e.g., nitroglycerin, dopamine, amrinone) and dose CSF pressure
Anesthetic agents, type and dose CSF removed
Blood and cerebrospinal fluid (CSF): glucose level, pH, and gases Aortic occlusion time
Demographic data (e.g., age, gender) Renal revascularization
Amount of aorta replaced Urine return time
Paraplegia
Seventeen patients developed paraplegia or para-
paresis: 5 (3.4%) of 147 in group A (expected = 31)
and 12 (21%) of 58 in group B (expected = 13). Of
the 17 deficit patients, eight patients awoke with and
remained paraplegic, four were paretic, two recovered
completely (i.e., the first two treated with naloxone),
and three had delayed deficits. Deficits occurred in 3
(2.36%) of the 127 patients undergoing elective oper-
ations and in 14 (17.9%) of 78 patients who had acute
presentations. No deficits occurred in patients with
acute or chronic thoracic aneurysms.
In group A, 1 of 95 (expected = 10) patients
undergoing elective operations and 4 of 51 (expect-
ed = 19) patients with acute presentations had
deficits. In group B, 2 of 31 (expected = 3) patients
undergoing elective operations and 10 of 27
(expected = 10) patients with acute presentations
had deficits. In the highest-risk group of 13 C2
patients with dissections (6 of 8 in group A and 4 of
5 in group B had acute presentations), 4 (80%) of 5
(3 acute) group B patients and 3 (37%) of 8 (all
acute) group A patients had deficits. The one group
A patient with a deficit who had elective treatment
had normal bladder and bowel functions and
resumed unassisted ambulation. Of the four acute-
presentation group A patients with deficits, three
had cardiac failure, and in one with a mycotic
aneurysm, a malfunctioning drain prevented CSF
drainage. All four of these patients died of car-
diopulmonary failure within a few days to weeks
after the operation.
Univariate analysis identified nine significant pre-
operative and operative factors for paraplegia risk
(Table IV). With the use of logistic regression, sev-
eral models were created to investigate the interac-
tions of these variables. In a model with all nine vari-
ables, only the variable group (A,B) (p < 0.03)
remained significant (group A had 1/40th the risk
of group B by odds ratio analysis). In a stepwise
deletion of this large model, the variables C2, acute
presentation, group B membership, and a change in
the cardiac index ( D C1) remained significant for
deficit risk (Table V).
Mortality
A total of 21 (9.7%) patients died: 18 (8.3%) with-
in 30 days of the operation and 3 (1.4%) later in the
hospital. Of the 21 patients who died, 19 (21% of 90)
had acute presentations, and 2 (1.6% of 127) had elec-
tive treatment. Seventy percent of the patients died of
rupture, shock, and arrest or of multisystem failure
(Table VI). Of the seven patients with multisystem fail-
ure, two had mycotic aneurysms (i.e., Clostridia per-
fringens and Staphylococcus aureus), three had cardiac
failure from myocardial ischemia (ejection fraction <
20%), and two had pulmonary failure with acute respi-
ratory distress syndrome and pneumonia.
By univariate analysis, six variables were signifi-
cantly correlated with the risk of death (Table VII).
Acute presentation, age, and preoperative creatinine
level values best correlated in the logistic regression
model with operative death (Table VIII).
Renal Function
Fifty-four (25%) patients had serum creatinine
levels higher than 1.6 mg/dl, and four patients were
on dialysis preoperatively. Sixty-six patients (30.4%)
had renal revascularization with endarterectomy
(54), autogenous artery (4), or synthetic bypass (8).
Renal revascularization patients had higher preoper-
ative serum creatinine levels (1.92 ± 0.13 versus
1.23 ± 0.09 mg/dl) but had greater improvement in
renal function postoperatively than nonrevascular-
ized patients (Fig. 1). Three (3%) patients who had
acute presentations and one (0.8%) patient who had
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Table III. Crawford type, clinical presentation,
and deficits
Type Number (%) Elective Acute Dissection Deficit
C1 35 (16) 21 14 9 3
C2 66 (30) 39 27 13 13
C3 29 (14) 19 10 2 0
C4 46 (21) 32 14 1 1
TA* 41 (19) 16 25 4 0
Total 217 (100) 127 90 29 17
C1, C2, C3, and C4, Crawford aneurysm types; TA, thoracic
aneurysm; Elective, patients undergoing elective operative treat-
ment; Acute, patients with acute clinical presentations; Dissection,
patients with acute or chronic dissections at presentation; Deficit,
patients with postoperative paraplegia.
*Patients with Stanford B dissections that were repaired with
short thoracic grafts were classified as TA. 
Table II. Causes of aneurysms
Type or cause* Number (%)
Atherosclerotic 164 (75.58)
Poststenotic from adult coarctation 2 (0.92)
Medial degenerative* 25 (11.52)
Lupus erythematosus 2 (0.92)
Mycotic 5 (2.30)
Takaysu’s arteritis 1 (0.46)
Traumatic, acute or chronic 18 (8.29)
*Most patients with dissection and younger nonatherosclerotic
patients were classified as having medial degenerative disease.
elective treatment were dialysis dependent postoper-
atively. Two of the acute-presentation, dialysis-
dependent patients died of multisystem failure, and
one recovered renal function. One of the four
patients who required dialysis preoperatively recov-
ered renal function with revascularization sufficient
to discontinue dialysis. The cause of renal failure in
the diabetic patient who had undergone elective
treatment was undetermined, but angiography
demonstrated normal flow in both renal arteries.
The only significant factor for an elevated postoper-
ative creatinine level was an elevated preoperative
creatinine level (p < 0.0001).
DISCUSSION
The results of this analysis are consistent with
and support our and others’ previous observations
that paraplegia risk depends on the amount of aorta
replaced and that the acute status of the dissection
significantly increases the risk of deficit.11-13
Univariate analysis showed that the following factors
correlated with deficit risk: temperature before aor-
tic occlusion, volume replacement, blood oxygen
level, aortic occlusion time, and cardiac index.
A change in the cardiac index with aortic occlu-
sion (Fig. 2) is the most important of the physiolog-
ic factors, and this factor remained significant in the
larger model containing the acute presentation, C2,
and group A,B variables. The significant drop in the
cardiac index in patients with deficits compared with
patients without deficits may reflect the important
contribution of cardiac function to the collateralized
circulation of the spinal cord during and after aortic
occlusion. The critical role of cardiac function in
peripheral and spinal cord perfusion is consistent
with the observation of delayed deficits and multi-
system failure in patients with “pump” failure post-
operatively. This report is the first documentation of
patient cardiac function as a factor in cord perfusion
and paraplegia.
Additional insight has been gained into the role
of the endorphin receptor antagonist naloxone.
Studies of the negative effects of excitatory and
inhibitory neurotransmitters in spinal cord ischemia
indicate that some of these effects can be antago-
nized by naloxone.14-19
With the previously demonstrated predictive para-
plegia model, the slope of the regression plot for esti-
mated versus actual deficits for a particular technique
of repair over time is an estimate of the paraplegia risk
for that technique (Table IX and Fig. 3).7,8,20-27
From this analysis, the estimated paraplegia risk for
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Table IV. Factors significantly associated with paralysis
Variable* N Deficit Chi-square p value
C2 Yes 65 13 17.15 <0.0001
No 140 4
Group A 147 5 16.35 <0.0001
B 58 12
Acute Yes 78 14 15.44 <0.0001
No 127 3
Variable Mean Deficit t test p value
T PRE 34.16 (0.9) N –2.56 <0.0113
34.85 (1.6) Y
Volume replacement (ml) 6880 N –3.11 <0.0022
10341 Y
PO2,1 325 N 2.24 <0.0265
244 Y
Occlusion time (min) 45.4 N –2.13 <0.0342
53.9 Y
Deficit CI1† CI2 CI3 Delta CI
Yes 2.75 ± 0.18 2.23 ± 0.19 2.90 ± 0.20 –0.58 ± 0.21
No 2.58 ± 0.06 2.83 ± 0.08 3.43 ± 0.09 0.28 ± 0.09
p value 0.43 0.028 0.075 0.0046
T PRE, Body temperature just before aortic occlusion; PO2,1, blood gas PO2 before aortic occlusion; CI, cardiac index.
*Nine factors had significant association with paralysis (i.e., deficit) risk by univariate analysis.
†Cardiac indices (CI1, CI2, CI3) refer to values before, during, and after aortic occlusion. Delta CI is the difference between CI2 and
CI1; a positive value means that the cardiac index increased with aortic occlusion, and a negative value means that it decreased.
our described technique of CSFD, naloxone adminis-
tration, and early ligation of intercostals without reim-
plantation (group A) is about one seventh of the risk
of graft inclusion and intercostal reimplantation with
or without assisted circulation and about one fourth
of the risk of CSFD and reimplantation. This model
analysis of deficit risk confirms our opinion that para-
plegia rates are predictable and uniform over time for
a particular technique of aneurysm repair.
In contrast to the findings for CSFD, hypother-
mia, and endorphin receptor blockade, no experi-
mental model supports intercostal reimplantation or
assisted circulation as methods to prevent paraple-
gia.2,28 Experimentally, even direct perfusion of the
arteria radicularis magna (artery of Adamkiewicz)
during aortic occlusion with reperfusion of all inter-
costals has no protective effect.29 There is also
strong experimental evidence that collateral blood
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Table V. Odds ratios for a multiple logistic regression model for paralysis
Multivariate analysis* Univariate analysis*
Term Odds ratio (95% CI) p value Odds ratio (95% CI) p value
C2 [N-Y] 0.028 (0.002–0.182) 0.0011 0.118 (0.032–0.349) 0.003
Group A [N-Y] 41.1 (7.05–430) 0.003 7.41 (2.60–24.3) 0.003
Acute [N-Y] 0.094 (0.010–0.507) 0.0134 0.111 (0.025–0.354) 0.008
Delta CI 2.78 (1.25–7.54) 0.0221 2.12 (1.26–3.79) 0.0066
Occlusion time 0.943 (0.873–1.00) 0.917 0.971 (0.944–1.00) 0.0424
T PRE 0.526 (0.229–1.07) 0.0878 0.545 (0.326–0.888) 0.0152
CI2 1.84 (0.539–7.26) 0.3501 2.07 (1.11–4.19) 0.0307
C2, Crawford type 2 aneurysm; N-Y, no or yes; group A, patients who received cerebrospinal fluid drainage (CSFD) and low-dose nalox-
one (1 m g/kg/hour) as adjuncts to reduce the risk of paralysis; group B, patients who did not receive CSFD and naloxone; Acute, patients
with acute clinical presentations; T PRE, body temperature just before aortic occlusion; Delta CI, change in cardiac index.
*The estimates were adjusted for C2, Treated, Acute, and Delta CI factors. The factors of extent of aortic replacement (C2), Acute,
treatment group, and Delta CI all remained significant factors for deficit risk. The receiver operating characteristic curve (c index) was
0.96 for this regression model. By odds ratio, group A had 2.5% of the risk of group B, the elective surgery group had 1/10th of the
risk of the acute-presentation group, and those with Crawford type 2 aneurysms had 36 times the risk of those that did not have type 2
aneurysms. Patients with a drop in cardiac index with aortic occlusion were at higher risk for deficit than those with no change.
Fig. 1. Regression plot for preoperative and postopera-
tive serum creatinine levels (mg/dl). The only significant
predictor of the postoperative creatinine level was the pre-
operative creatinine level (p < 0.0001). With the slope of
the regression line used as a measure of renal function
before and after aneurysm repair, patients with renal revas-
cularization had improved renal function (slope = 0.55)
compared with patients who did not (slope = 0.91). 
Fig. 2. Plot of the cardiac index (CI) before (CI1), dur-
ing (CI2), and after (CI3) aortic occlusion in patients
with and without deficits. The change in CI with aortic
occlusion (delta CI) was a significant factor for paraplegia
risk and may reflect the heart’s ability to augment collat-
eral blood flow to the spinal cord.
flow during aortic occlusion is an important factor in
cord preservation30 and that chemical or mechanical
shunting of blood away from the cord collaterals
(especially the upper thoracic intercostals) has a sig-
nificant negative effect on spinal cord viability.31,32
Our paraplegia risk model analysis of clinical reports
strongly implies that intercostal reimplantation dur-
ing aortic occlusion offers no protection from para-
plegia, with or without assisted circulation.
Our practice of quickly oversewing intercostals
may improve collateral blood flow to the spinal cord
during aortic occlusion by increasing pressure in the
collateral bed. The observations of Griepp et al.24
support this possibility, and the more aggressive lig-
ation of thoracic intercostals reported by Safi33 and
Coselli11 may be an explanation for their improved
results with more limited reimplantation.
Relevant to the reimplantation debate is the tech-
nique of epidural cooling described by Davison,10,34
which is associated with a low risk of paraplegia that
approximates ours (regression slope = 0.18). The tech-
nique’s increased hypothermic protection of the spinal
cord may allow safer intercostal reimplantation by
making collateral blood flow during aortic occlusion
less important for cord perfusion. It also may offer
hypothermic cord protection without the higher risks
of hypothermic circulatory arrest.35,36 Although tem-
perature in our analysis was not a major effect com-
pared with cardiac function, the protective effects of
moderate hypothermia may be substantial and graded
by small differences in temperature. This graded effect
could improve the paraplegia rates of normothermic
CSFD reported by Safi20; the improved effect is
implied by the results of hypothermic CSFD reported
by Frank.37
The aggressive use of renal revascularization and
perfusion in cooling the kidney may account for our
low rate of renal failure compared with those of
other reports.38 Renal function, acute presentation,
and age were the factors that most significantly cor-
related with risk of death in our analysis (Table
VIII); however, patients who died of rupture, shock,
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Fig. 3. Paraplegia risk by technique of repair. In the
regression plot of predicted versus actual number of
deficits, the slope is an estimate of the paraplegia risk of
that technique of repair, which is predictable and stable
over time. Graft inclusion and intercostal reimplantation
with or without assisted circulation had identical and per-
fectly predictable (slope = 0.98) paraplegia risks. XCLMP,
cross clamp; AFB, assisted circulation; CSFD, cere-
brospinal fluid drainage; GROUP A, patients who
received CSFD and low-dose naloxone (1 m g/kg/hour) as
adjuncts to reduce the risk of paralysis.
Table VI. Causes of operative death
Cause of operative death N (%)
Cardiac 3 (14.28)
Cerebrovascular accident 2 (9.52)
Gastrointestinal bleeding 1 (4.76)
Multisystem failure 7 (33.33)
Rupture, shock, and arrest 8 (38.10)
Total 21
Most patients who died of rupture, shock, and arrest or multisys-
tem failure deaths had cardiac arrest or cardiac failure from
ischemic heart disease.
Table VII. Univariate analysis of factors correlat-
ing with operative mortality
Variable Patients Operative deaths Chi-square p value
Acute N 127 2 22.9 <0.0001
Y 90 19
Deficit N 188 6 7.76 <0.006
Y 17 3
Group A 150 10 5.04 <0.03
B 67 11
Variable Operative death Mean t test p value
Age N 65.9 (0.98) –3.12 0.002
Y 75.8 (2.98)
Preop. Cr. N 1.45 (0.08) –2.62 0.0091
Y 2.19 (0.27)
Delta CI N 0.221 (0.09) 2.13 0.035
Y –0.614 (0.38)
Preop. Cr., Preoperative serum creatinine (mg/dl); Acute, patients
with acute clinical presentations; group A, patients who received
cerebrospinal fluid drainage (CSFD) and low-dose naloxone (1
m g/kg/hour) as adjuncts to reduce the risk of paralysis; group B,
patients who did not receive CSFD and naloxone; Delta CI,
change in cardiac index.
and arrest usually had ischemic cardiac disease,
which is associated with age and renal insufficiency.
The two deaths of patients who had undergone elec-
tive treatment were not cardiac related (i.e., pul-
monary embolus and gram-negative pneumonia
with acute respiratory distress syndrome).
In summary, our own experience with CSFD
and naloxone without intercostal reimplantation
has shown that the risk of paraplegia can be reduced
to about one seventh of the risk of the graft inclu-
sion and intercostal reimplantation technique, with
or without assisted circulation. Others’ experience
with epidural cooling, CSFD with assisted circula-
tion and hypothermia,37 and intercostal perfusion
cooling39 approximates our results for paraplegia
reduction and reinforces our observation that com-
bining the overlapping effects of factors (e.g.,
hypothermia, CSFD, endorphin blockade) that
have been shown experimentally to decrease spinal
cord injury during aortic occlusion can significantly
reduce the risk of paraplegia in thoracoabdominal
aneurysm repair. Reduced cardiac function also
restricts spinal cord perfusion and may be a limiting
factor, with or without intercostal reimplantation,
in paraplegia prevention.
We are grateful for the assistance of Dennis Heisey,
MD, with the statistical analysis of the data.
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Dr. Peter Gloviczki (Rochester, Minn.). I would like
to congratulate Dr. Acher for his presentation and for the
truly excellent surgical results of a large series of thoracic
and thoracoabdominal aortic aneurysms. In 217 consecu-
tive patients, the authors used no assisted circulation and
no intercostal implantation. Cerebrospinal fluid drainage
and low-dose intravenous naloxone hydrochloride were
used for spinal cord protection. The authors offered a
mortality rate of 9.7% and the codeficit of 7.2%, which is
truly remarkable considering that 90 patients in this series
had free or contained rupture or acute dissection. The
authors concluded that cerebrospinal fluid drainage and
naloxone hydrochloride significantly decreased the rate of
paraplegia to 3.4% compared with an incidence rate of 21%
when these adjuncts were not used.
The few who have performed this operation know the
frustration of seeing a patient with paraplegia after a
seemingly uneventful but heroic operation. After Dr.
Crawford’s death, attempts to decrease the rate of para-
plegia have been directed to the more frequent use of
assisted circulation and to epidural cooling of the spinal
cord. We have used epidural cooling in our experience
with 70 patients. Unfortunately, our rate of paraplegia
was still 10%, which is similar to our history of controls
presented here. We have a rate of paraplegia of 8.9% with
206 patients. Even with the type II cases with cooling, we
had a 25% deficit rate that was 26% in our previous group.
So we are looking for methods and adjuncts to protect
the cord.
Dr. Acher presented a complex and thorough statisti-
cal analysis to support his conclusions, and my questions
to him will start with the statistical methods that he used.
I have no question that comparison of the risk of paraple-
gia in group A versus group B yields a highly significant
difference. In a review of the analysis, however, the signif-
icance of the effects of drainage and naloxone hydrochlo-
ride remains less convincing. I have two reasons for this
belief, and I would like to ask Dr. Acher to comment on
both reasons.
First, as the authors looked for risk of paraplegia, they
evaluated 80 potential risk factors. So a greater than 98%
chance exists that one or more of these 80 significance
tests would be significant by chance alone. Therefore the
probability of type I error is almost 1. The author has eval-
uated 10 significant risk factors when only 17 events, or
17 deficits, exist. Our statisticians recommend that any
model should have at least 10 events for each risk factor. A
model with 10 risk factors and 17 events therefore appears
quite unreliable.
My next question concerns the effect of naloxone
hydrochloride on protection of the spinal cord. This effect
can depend greatly on the dose of opioids given for anes-
thesia. Do your anesthesiologists use the same dose of opi-
oids in every patient, or do you change the amount of
naloxone hydrochloride infused depending on the dose of
fentanyl citrate or morphine given for anesthesia?
I also have a question that concerns your desire to lig-
ate all intercostal arteries. The problem is significant. For
those of us who believe that the anterior spinal cord has a
critical blood supply through the artery of Adamkiewicz,
routine ligation of this artery appears hazardous. Is the
concept of critical blood supply to the anterior cord
flawed? What is the pathway of circulation when you lig-
ate all intercostal arteries? Finally, do you think that any of
the 17 patients with cord deficit in your series might have
had the deficit because of ligation of the critical vessels to
the cord?
I would like to congratulate you again for the truly
outstanding results of this series, and I would like to thank
the society for the opportunity to discuss this important
paper. Thank you.
Dr. Charles W. Acher. Thank you Dr. Gloviczki for
your questions. They certainly are relevant, and I will see
if I can answer them in a relevant way. The statistical analy-
sis we used to evaluate this study was an attempt to iden-
tify factors that may be relevant to risk of paraplegia, mor-
tality, and renal failure. The problem with a large multi-
variant model and a small number of effects is that factors
that would be significant otherwise may be excluded. Any
factors that are present in a large multivariate model and
remain significant are highly significant indeed. The only
factor that remained significant in our larger multivariate
model was the use of naloxone and cerebrospinal fluid
damage. The fact that this remained significant in this
large model means that it had a very powerful effect when
other factors were taken into account. However, we also
used also a stepwise deletion method to arrive at a much
smaller model with only three or four variables, especially
for risk of paralysis. The paralysis model was highly signif-
icant, with an r2 value of 0.55 with only four variables, all
of which remained significant. When statistics are used in
this way to uncover complex associations, they are, of
course, statistically valid in the smaller model. Other fac-
tors that were not significant and help us understand the
relationships between complex variables that are the most
important for a given effect still may have some effect, but
the factors  identified in the model were the most impor-
tant and statistically relevant in prediction of paraplegia.
As for the question of fentanyl citrate and morphine,
we of course feel strongly that endorphin-like opioids have
a negative effect on spinal-cord blood flow and survival of
stressed neurons. The experimental literature is replete
with these negative effects to injured neurons. Some
recent evidence shows that excitatory neurotransmitters
also may play an active role in spinal-cord damage from
ischemia and that naloxone also may block the excitatory
neurotransmitter effect. Fentanyl citrate and morphine act
much differently in their analgesic effect and systemic
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effect. For instance, fentanyl citrate enhances spinal-cord
blood flow, and morphine depresses spinal-cord blood
flow. The variable effects of such drugs are poorly under-
stood at best, but morphine is the closest drug we have to
beta endorphin, which has the most potent vasoconstric-
tive and negative effects on the survivability of spinal neu-
rons. Therefore, we do avoid the use of morphine.
The question of intercostal reimplantation obviously is
controversial. Surgeons have been fused at the hip to a very
narrow paradigm of paraplegic prevention and causation,
which was first developed and outlined in some detail by
Adams and Van Geertuyden in the mid 1950s. This para-
digm correctly stressed that interruption of intercostal
blood flow was a major contributing factor to spinal cord
infarction and the resulting paraplegia. However, since that
time, unfortunately, no one has developed an experimental
model that shows that intercostal reimplantation prevents
spinal cord stroke in thoracoabdominal aortic replacement.
This is true even if the arteria magna radicularis is perfused
directly, as done in a series of experiments from your own
institution. Because of the ineffectiveness of intercostal
reimplantation and the association that Crawford initially
made with attempted reimplantation and higher risk of
paraplegia, we decided to pursue a different paradigm to
improve clinical results. Instead of relying on the Adams
paradigm, we consciously chose to pursue a paradigm of
maximizing collateral blood flow in the intercostal bed in
attempt to improve spinal cord perfusion during the peri-
od of aortic occlusion. It was predicated on the observation
that in the attempt to reimplant intercostals a great deal of
shunting away from the cord occurs through backbleeding
intercostals. This negative effect of open intercostals has
been confirmed experimentally. I think there are some cir-
cumstances under which intercostals can be more safely
reattached, and that is in the case specifically of hypother-
mic circulatory arrest. Clearly, with hypothermic circulato-
ry arrest, the central nervous system is protected by pro-
found hypothermia; however, the risk of hypothermic cir-
culatory arrest in thoracoabdominal replacement is of
significantly higher mortality rate in most reports that use
this technique. The approach that we have outlined, which
includes intercostal ligation, has reduced the paraplegia
rate in elective patients by a factor of 10, and in those
patients who present acutely by a factor of 5 to 7. This is
without any intercostal reimplantation. Our results support
the paradigm of enhancing collateral blood flow as a way of
improving spinal cord perfusion and reducing the risk of
paraplegia. I think you captured it best in your comments
when you indicated that you strongly believe in the neces-
sity of the artery of Adamkiewicz. We have taken the
approach that belief is to be substantiated by clinical and
experimental evidence that supports that belief. As of this
date, in thoracoabdominal aortic replacement, reimplanta-
tion has not been established experimentally or clinically as
an effective way to prevent paraplegia. However, from our
work, it does appear that by ligation we can enhance col-
lateral blood flow during occlusion and thus reduce the risk
of neurologic deficit.
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